Text Size: A A
View Comments
Pharmaceutical Innovation and Essential Medicines
By Thomas W. Pogge, Christian Barry, Matt Peterson
Centre for Applied Philosophy and Public Ethics, Carnegie Council for Ethics in International Affairs, Public Ethics Media, September 3, 2008
Thomas Pogge explains his proposal for dealing with the thorny intersection of public health, intellectual property rights, and poverty. As he sees it, the patent system doesn't work as well for medicines as it does for, say, consumer electronics. Please visit Public Ethics Radio to read more about this broadcast.
Public Ethics Radio is a production of the Centre for Applied Philosophy and Public Ethics (CAPPE) in Canberra, Australia—the world's largest concentration of applied philosophers—in association with the Carnegie Council.
Public Ethics Radio is hosted by Christian Barry and produced by Matt Peterson. Find out more by visiting http://publicethicsradio.org/ or writing to contact@publicethicsradio.org.
| This content is licensed under a Creative Commons License. Please read our usage policy. |
Read More: Aid, Business, Development, Ethics, Finance, Health, Human Rights, Innovation, Science, Technology, Africa, Global
- WHO Pushes Pharmaceutical Innovation (Briefings)
- Reward Pharmaceutical Innovators in Proportion to the Health Impact of Their Invention (Innovations)
- The Determinants of Pharmaceutical Research and Development Investments (Policy Library)
- Access to Medicine Index (Policy Library)
- Preserving PEPFAR (Briefings)
- Prizes, Not Patents (Commentary)
- Merck's Dubai Ethics Center (Innovations)
- The International AIDS Vaccine Initiative Story (Innovations)
- The Cycle of AIDS and Hunger in Africa (Commentary)
- Patent Absurdity (Briefings)
TWITTER
Follow us on Twitter.
> Go
FACEBOOK
Become a friend on Facebook.
> Go
PODCAST
Subscribe to the Carnegie Council Podcast.
> Go
RSS Feed
Subscribe to our RSS Feed.
> Go